Blended Collaborative Care for Heart Failure and Co-Morbid Depression
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Listed as NCT02044211, this PHASE2/PHASE3 trial focuses on Cardiovascular Disease and Depression and remains completed. Sponsored by National Heart, Lung, and Blood Institute (NHLBI), it has been updated 9 times since 2014, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2/PHASE3
Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE2_PHASE3
-
Sep 2020 — Jan 2021 [monthly]
Completed PHASE2_PHASE3
Status: Active Not Recruiting → Completed
-
Oct 2019 — Sep 2020 [monthly]
Active Not Recruiting PHASE2_PHASE3
▶ Show 4 earlier versions
-
Mar 2019 — Oct 2019 [monthly]
Active Not Recruiting PHASE2_PHASE3
-
Jun 2018 — Mar 2019 [monthly]
Active Not Recruiting PHASE2_PHASE3
-
Jan 2018 — Jun 2018 [monthly]
Active Not Recruiting PHASE2_PHASE3
Status: Recruiting → Active Not Recruiting
-
Jan 2017 — Jan 2018 [monthly]
Recruiting PHASE2_PHASE3
First recorded
Feb 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Heart, Lung, and Blood Institute (NHLBI)
- University of Pittsburgh
For direct contact, visit the study record on ClinicalTrials.gov .